1160653-95-1

Basic information

• Product Name: 3-bromo-2-fluoro-6-hydroxybenzaldehyde
• Synonyms: 3-bromo-2-fluoro-6-hydroxybenzaldehyde
• CAS NO: 1160653-95-1
• Molecular Formula: C₇H₄BrFO₂
• Molecular Weight: 219.0078632
• Mol File: 1160653-95-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-bromo-2-fluoro-6-hydroxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-2-fluoro-6-hydroxybenzaldehyde(1160653-95-1)
• EPA Substance Registry System: 3-bromo-2-fluoro-6-hydroxybenzaldehyde(1160653-95-1)

Safety Data

• Hazardous Substances Data: 1160653-95-1(Hazardous Substances Data)

Usage

General Description

3-bromo-2-fluoro-6-hydroxybenzaldehyde is a chemical compound with the molecular formula C7H4BrFO2. It is a member of the benzaldehyde family and contains bromine, fluorine, and hydroxyl functional groups. 3-bromo-2-fluoro-6-hydroxybenzaldehyde is commonly used in synthetic organic chemistry and pharmaceutical research as an intermediate for the production of various drugs and other organic compounds. It is a light yellow to brown colored solid with a slightly fruity odor. 3-bromo-2-fluoro-6-hydroxybenzaldehyde is known for its potential as a building block in the development of new pharmaceuticals and agrochemicals due to its unique chemical properties and reactivity in organic synthesis.

Upstream product

• 149947-15-9 3-bromo-2-fluorobenzaldehyde 
• 1160653-94-0 3-bromo-2-fluoro-6-methoxybenzaldehyde 
• 458-50-4 1-bromo-2-fluoro-4-methoxybenzene 

Relevant articles and documents

METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY

Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.

FURTHER HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV

The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising thes

IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

A series of substituted 3H imidazo[4,5-b]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.